Functional characterization of tumor‐infiltrating lymphocytes, lymph‐node lymphocytes and peripheral‐blood lymphocytes from patients with breast cancer
- 19 August 1991
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 49 (1) , 25-31
- https://doi.org/10.1002/ijc.2910490106
Abstract
Mononuclear cell infiltration is frequently seen within human solid tumors. Effector cells within the tumor site usually fail to exhibit cytotoxic or natural killer activity when freshly isolated; however, they develop potent and sometimes specific cytotoxicity after expansion in IL2. Thus, local tumor environment may influence lymphocyte function. In our study, we disaggregated human breast‐cancer and lymph‐node tissue to obtain lymphocyte‐enriched cell fractions. Besides phenotypic analysis, functional characterization with regard to proliferation and cytokine production of tumor‐infiltrating lymphocytes (TIL), peripheral‐blood lymphocytes (PBL) and lymph‐node lymphocytes (LNL) was the aim of our study. TIL showed an enrichment of CD8+ cells with a corresponding decrease in CD4+ cells in comparison with PBL and LNL. In response to PHA, TIL showed decreased 3H‐thymidine uptake, but TIL were significantly stimulated by rhlL2. TIL produced low levels of ID, TNF and IFNγ upon mitogen/phorbol ester stimulation, while PBL produce high levels of TNF and IFNγ but low levels of IL2. Under the same experimental conditions, LNL produce high levels of TNF and IL2 but low levels of IFNγ. Mitogen‐mediated TNF secretion was increased after addition of autologous tumor cells in TIL and LNL, whereas IFNγ secretion tended to be suppressed. Our results indicate different patterns of activities of TIL, LNL and PBL from breast‐cancer patients.Keywords
This publication has 21 references indexed in Scilit:
- Human gene transfer: characterization of human tumor-infiltrating lymphocytes as vehicles for retroviral-mediated gene transfer in man.Proceedings of the National Academy of Sciences, 1990
- Stimulation of FACS-analysed CD4+ and CD8+ human tumour-infiltrating lymphocytes with ionomycin + phorbol-12, 13-dibutyrate does not overcome their proliferative deficitClinical and Experimental Immunology, 1990
- Inhibition of lymphocyte function by glioblastoma-derived transforming growth factor β2Journal of Neurosurgery, 1989
- Regulation of tumor necrosis factor gene expression in colorectal adenocarcinoma: in vivo analysis by in situ hybridization.Proceedings of the National Academy of Sciences, 1989
- Different immune functions of peripheral blood, regional lymph node, and tumor infiltrating lymphocytes in lung cancer patientsCancer, 1988
- Tumor necrosis factors alpha and beta in acquired immunodeficiency syndrome (AIDS) and aids-related complexJournal of Clinical Immunology, 1987
- In vitro expression of secondary antitumor immunity by in vivo tumor-sensitized T cells: Inhibition by tumor-induced suppressor T cellsCancer Immunology, Immunotherapy, 1987
- Expansion of human tumor infiltrating lymphocytes for use in immunotherapy trialsJournal of Immunological Methods, 1987
- A New Approach to the Adoptive Immunotherapy of Cancer with Tumor-Infiltrating LymphocytesScience, 1986
- Rapid colormetric assay for cell viability: Application to the quantitation of cytotoxic and growth inhibitory lymphokinesJournal of Immunological Methods, 1984